Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 547-560 , December 2006

The genetics of ACTH resistance syndromes

  • Louise A. Metherell, PhD (Senior Postdoctoral Fellow in Professor Clark's lab)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 7882 6241; Fax: +44 20 7882 6197.
  • Li F. Chan, MRCPCH (Clinical Research Training Fellow in Professor Clark's lab)

References 

  1. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. European Journal of Endocrinology. 2003;149:79–90
  2. Getting SJ. Targeting melanocortin receptors as potential novel therapeutics. Pharmacology and Therapeutics. 2006;111:1–15
  3. Prpic I, Huebner A, Persic M, et al. Triple A syndrome: genotype-phenotype assessment. Clinical Genetics. 2003;63:415–417
  4. Houlden H, Smith S, De Carvalho M, et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain. 2002;125:2681–2690
  5. Persic M, Prpic I, Huebner A, et al. Achalasia, alacrima, adrenal insufficiency, and autonomic dysfunction: double A, triple A, or quaternary A syndrome?. Journal of Pediatric Gastroenterology and Nutrition. 2001;33:503–504
  6. Weber A, Wienker TF, Jung M, et al. Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Human Molecular Genetics. 1996;5:2061–2066
  7. Tullio-Pelet A, Salomon R, Hadj-Rabia S, et al. Mutant WD-repeat protein in triple-A syndrome. Nature Genetics. 2000;26:332–335
  8. Handschug K, Sperling S, Yoon SJ, et al. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Human Molecular Genetics. 2001;10:283–290
  9. Lam YY, Lo IF, Shek CC, et al. Triple-A syndrome – the first Chinese patient with novel mutations in the AAAS gene. Journal of Pediatric Endocrinology and Metabolism. 2006;19:765–770
  10. Sandrini F, Farmakidis C, Kirschner LS, et al. Spectrum of mutations of the AAAS gene in Allgrove syndrome: lack of mutations in six kindreds with isolated resistance to corticotropin. The Journal of Clinical Endocrinology and Metabolism. 2001;86:5433–5437
  11. Huebner A, Kaindl AM, Knobeloch KP, et al. The triple A syndrome is due to mutations in ALADIN, a novel member of the nuclear pore complex. Endocrine Research. 2004;30:891–899
  12. Brooks BP, Kleta R, Stuart C, et al. Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000-2005. Clinical Genetics. 2005;68:215–221
  13. Storr HL, Clark AJ, Priestley JV, et al. Identification of the sites of expression of triple A syndrome mRNA in the rat using in situ hybridisation. Neuroscience. 2005;131:113–123
  14. Huebner A, Mann P, Rohde E, et al. Mice lacking the nuclear pore complex protein ALADIN show female infertility but fail to develop a phenotype resembling human triple A syndrome. Molecular and Cellular Biology. 2006;26:1879–1887
  15. Shepard TH, Landing BH, Mason DG. Familial Addison's disease; case reports of two sisters with corticoid deficiency unassociated with hypoaldosteronism. American Journal of Diseases of Children. 1959;97:154–162
  16. Stempfel RS, Engel FL. A congenital, familial syndrome of adrenocortical insufficiency without hypoaldosteronism. The Journal of Pediatrics. 1960;443–451
  17. Migeon CJ, Kenny EM, Kowarski A, et al. The syndrome of congenital adrenocortical unresponsiveness to ACTH. Report of six cases. Pediatric Research. 1968;2:501–513
  18. Kelch RP, Kaplan SL, Biglieri EG, et al. Hereditary adrenocortical unresponsiveness to adrenocorticotropic hormone. The Journal of Pediatrics. 1972;81:726–736
  19. Thistlethwaite D, Darling JA, Fraser R, et al. Familial glucocorticoid deficiency. Studies of diagnosis and pathogenesis. Archives of Disease in Childhood. 1975;50:291–297
  20. Ramachandran P, Penhoat A, Naville D, et al. Familial glucocorticoid deficiency type 2 in two neonates. Journal of Perinatology. 2003;23:62–66
  21. Elias LL, Huebner A, Metherell LA, et al. Tall stature in familial glucocorticoid deficiency. Clinical Endocrinology (Oxford). 2000;53:423–430
  22. Imamine H, Mizuno H, Sugiyama Y, et al. Possible relationship between elevated plasma ACTH and tall stature in familial glucocorticoid deficiency. The Tohoku Journal of Experimental Medicine. 2005;205:123–131
  23. Lin L, Hindmarsh PC, Metherell L et al. Severe loss-of-function mutations in the adrenocorticotrophin receptor (ACTHR, MC2R) can be found in induviduals diagnosed with salt-losing adrenal hypoplasia. Clinical Endocrinology (Oxford) [in press].
  24. Mountjoy KG, Robbins LS, Mortrud MT, et al. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992;257:1248–1251
  25. Clark AJ, McLoughlin L, Grossman A. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet. 1993;341:461–462
  26. Tsigos C, Arai K, Hung W, et al. Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. The Journal of Clinical Investigation. 1993;92:2458–2461
  27. Weber A, Clark AJ. Mutations of the ACTH receptor gene are only one cause of familial glucocorticoid deficiency. Human Molecular Genetics. 1994;3:585–588
  28. Genin E, Huebner A, Jaillard C, et al. Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity. Human Genetics. 2002;111:428–434
  29. Stenson PD, Ball EV, Mort M, et al. Human Gene Mutation Database (HGMD): 2003 update. Human Mutation. 2003;21:577–581
  30. Weber A, Kapas S, Hinson J, et al. Functional characterization of the cloned human ACTH receptor: impaired responsiveness of a mutant receptor in familial glucocorticoid deficiency. Biochemical and Biophysical Research Communications. 1993;197:172–178
  31. Naville D, Barjhoux L, Jaillard C, et al. Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency. The Journal of Clinical Endocrinology and Metabolism. 1996;81:1442–1448
  32. Naville D, Barjhoux L, Jaillard C, et al. Stable expression of normal and mutant human ACTH receptor: study of ACTH binding and coupling to adenylate cyclase. Molecular and Cellular Endocrinology. 1997;129:83–90
  33. Elias LL, Huebner A, Pullinger GD, et al. Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. The Journal of Clinical Endocrinology and Metabolism. 1999;84:2766–2770
  34. Tsigos C, Arai K, Latronico AC, et al. A novel mutation of the adrenocorticotropin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid deficiency, but no ACTH-R abnormalities in two families with the triple A syndrome. The Journal of Clinical Endocrinology and Metabolism. 1995;80:2186–2189
  35. Wu SM, Stratakis CA, Chan CH, et al. Genetic heterogeneity of adrenocorticotropin (ACTH) resistance syndromes: identification of a novel mutation of the ACTH receptor gene in hereditary glucocorticoid deficiency. Molecular Genetics and Metabolism. 1998;64:256–265
  36. Schimmer BP, Kwan WK, Tsao J, et al. Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor. Journal of Cellular Physiology. 1995;163:164–171
  37. Yang YK, Ollmann MM, Wilson BD, et al. Effects of recombinant agouti-signaling protein on melanocortin action. Molecular Endocrinology. 1997;11:274–280
  38. Noon LA, Franklin JM, King PJ, et al. Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. The Journal of Endocrinology. 2002;174:17–25
  39. Metherell LA, Chapple JP, Cooray S, et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nature Genetics. 2005;37:166–170
  40. Chan LF, Metherell LA, Naville D, et al. A novel mutation of MRAP (melanocortin 2 receptor accessory protein) gene in two brothers with familial glucocorticoid deficiency. Boston: The Endocrine Society – Endocrine Abstracts; 2006;p. 6
  41. Modan-Moses D, Ben Zeev B, Hoffmann C, et al. Unusual presentation of familial glucocorticoid deficiency (FGD) with a novel MRAP mutation. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3713–3717
  42. Xu A, Choi KL, Wang Y, et al. Identification of novel putative membrane proteins selectively expressed during adipose conversion of 3T3-L1 cells. Biochemical and Biophysical Research Communications. 2002;293:1161–1167
  43. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998;393:333–339
  44. Muff R, Leuthauser K, Buhlmann N, et al. Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells. FEBS Letters. 1998;441:366–368
  45. Saito H, Kubota M, Roberts RW, et al. RTP family members induce functional expression of mammalian odorant receptors. Cell. 2004;119:679–691

PII: S1521-690X(06)00073-X

doi: 10.1016/j.beem.2006.09.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 547-560 , December 2006

Article Tools

* Image Usage & Resolution